Affect of serum leptin on nutritional status in renal disease

被引:10
作者
Norton, PA [1 ]
机构
[1] Clin Comp Inc, Cincinnati, OH 45203 USA
关键词
D O I
10.1016/S0002-8223(02)90248-8
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Protein-energy malnutrition is a major comorbid condition in persons with renal disease. A variety of interventions have been implemented to supplement protein and energy intake in malnourished patients with renal disease, but the prevalence of protein-energy malnutrition remains high. Leptin, a hormone secreted by adipose tissue, decreases food intake via neuroendocrine systems in the hypothalamus in persons with normal renal function. Serum leptin levels are elevated in patients with chronic renal insufficiency and end-stage renal disease, and experimental evidence suggests a possible role for leptin in the development of protein-energy malnutrition in this population, Release of leptin from adipocytes may be stimulated by cytokines mediating the inflammatory response, which is frequently pronounced in patients with end-stage renal disease receiving hemodialysis and peritoneal dialysis. This article provides an overview of research conducted on serum leptin levels in different stages of renal disease, and the relationship among serum leptin, body composition, biochemical indexes, and markers of inflammation in persons with end-stage renal disease. Effects of intradialytic parenteral nutrition and anabolic factors on leptin levels and nutritional status are briefly reviewed.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 64 条
[1]   Modern medical management of obesity: The role of pharmaceutical intervention [J].
Aronne, LJ .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1998, 98 (10) :S23-S26
[2]   Impaired transport of leptin across the blood-brain barrier in obesity [J].
Banks, WA ;
DiPalma, CR ;
Farrell, CL .
PEPTIDES, 1999, 20 (11) :1341-1345
[3]   Dealing with diabetic nephropathy - A complication that can be avoided, detected, and treated [J].
Bell, DSH ;
Alele, J .
POSTGRADUATE MEDICINE, 1999, 105 (02) :83-+
[4]  
Bergstrom J, 1999, J Ren Nutr, V9, P129, DOI 10.1016/S1051-2276(99)90050-X
[5]   Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1 beta [J].
BretDibat, JL ;
Creminon, C ;
Couraud, JY ;
Kelley, KW ;
Dantzer, R ;
Kent, S .
BRAIN RESEARCH BULLETIN, 1997, 42 (06) :443-449
[6]   Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency [J].
Dagogo-Jack, S ;
Franklin, SC ;
Vijayan, A ;
Liu, J ;
Askari, H ;
Miller, SB .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (11) :1110-1115
[7]  
Daschner M, 1998, J AM SOC NEPHROL, V9, P1074
[8]  
De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846
[9]  
DOCCI D, 1990, CLIN NEPHROL, V34, P88
[10]  
Don BR, 2001, KIDNEY INT, V59, P1114